Total Payments
$359.36
2024 Payments
$15.72
Companies
11
Transactions
19
Medicare Patients
1,594
Medicare Billing
$170,693
Payment Breakdown by Category
Food & Beverage$359.36 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $359.36 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $105.41 | 1 | $0 (2018) |
| ABBVIE INC. | $47.33 | 3 | $0 (2023) |
| Genentech USA, Inc. | $44.03 | 2 | $0 (2019) |
| IMPEL PHARMACEUTICALS INC. | $33.65 | 2 | $0 (2023) |
| GENZYME CORPORATION | $27.40 | 2 | $0 (2017) |
| Biogen, Inc. | $23.23 | 1 | $0 (2017) |
| Allergan, Inc. | $22.33 | 2 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $15.72 | 1 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $14.77 | 1 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $13.34 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.72 | 1 | Novartis Pharmaceuticals Corporation ($15.72) |
| 2023 | $46.79 | 3 | IMPEL PHARMACEUTICALS INC. ($33.65) |
| 2022 | $61.11 | 4 | ABBVIE INC. ($34.19) |
| 2020 | $11.20 | 1 | Allergan, Inc. ($11.20) |
| 2019 | $23.37 | 1 | Genentech USA, Inc. ($23.37) |
| 2018 | $105.41 | 1 | Abbott Laboratories ($105.41) |
| 2017 | $95.76 | 8 | GENZYME CORPORATION ($27.40) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/13/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $15.72 | General |
| 12/07/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $17.40 | General |
| Category: Neurology | ||||||
| 10/25/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $16.25 | General |
| Category: Neurology | ||||||
| 05/10/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2022 | Janssen Pharmaceuticals, Inc | Ponvory (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Neuroscience | ||||||
| 06/01/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: NEUROSCIENCE | ||||||
| 01/03/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: PRIMARY CARE | ||||||
| 12/08/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2019 | Genentech USA, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Immunology | ||||||
| 09/07/2018 | Abbott Laboratories | Infinity DBS Pulse Generators (Device) | Food and Beverage | In-kind items and services | $105.41 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 06/19/2017 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $4.59 | General |
| Category: CNS | ||||||
| 05/26/2017 | Genentech USA, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Immunology | ||||||
| 05/11/2017 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA, ZINBRYTA | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: NEUROLOGY | ||||||
| 03/13/2017 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: CNS | ||||||
| 03/03/2017 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 02/14/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2017 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 01/09/2017 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $4.56 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 389 | 454 | $94,598 | $40,305 |
| 2022 | 7 | 348 | 429 | $81,711 | $36,803 |
| 2021 | 7 | 420 | 499 | $94,359 | $46,558 |
| 2020 | 7 | 437 | 530 | $98,773 | $47,027 |
Total Patients
1,594
Total Services
1,912
Medicare Billing
$170,693
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 67 | 71 | $22,933 | $9,496 | 41.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 86 | $15,050 | $7,426 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 96 | 107 | $13,375 | $6,026 | 45.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 29 | 46 | $9,660 | $3,233 | 33.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $8,160 | $3,112 | 38.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 46 | $5,290 | $2,724 | 51.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $5,940 | $2,572 | 43.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 24 | 26 | $4,160 | $2,356 | 56.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 14 | $3,430 | $1,716 | 50.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 12 | 12 | $6,600 | $1,645 | 24.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 56 | 57 | $18,393 | $8,715 | 47.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 97 | 121 | $15,426 | $6,546 | 42.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 49 | $8,085 | $4,440 | 54.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 39 | 78 | $8,970 | $4,386 | 48.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 40 | 40 | $10,187 | $3,942 | 38.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 29 | 42 | $8,820 | $3,262 | 37.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $6,120 | $2,767 | 45.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 18 | 18 | $5,710 | $2,746 | 48.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 91 | 94 | $28,670 | $14,259 | 49.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 111 | 140 | $14,840 | $8,213 | 55.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 55 | 55 | $13,310 | $5,610 | 42.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 54 | $8,478 | $5,436 | 64.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 44 | 67 | $7,705 | $3,775 | 49.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $7,502 | $3,271 | 43.6% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 25 | 40 | $8,400 | $3,055 | 36.4% |
About Dr. Robert Richardson, M.D
Dr. Robert Richardson, M.D is a Neurology healthcare provider based in Bedford, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285671578.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Richardson, M.D has received a total of $359.36 in payments from pharmaceutical and medical device companies, with $15.72 received in 2024. These payments were reported across 19 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($359.36).
As a Medicare-enrolled provider, Richardson has provided services to 1,594 Medicare beneficiaries, totaling 1,912 services with total Medicare billing of $170,693. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Bedford, OH
- Active Since 06/02/2006
- Last Updated 11/15/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1285671578
Products in Payments
- Infinity DBS Pulse Generators (Device) $105.41
- OCREVUS (Biological) $44.03
- QULIPTA (Drug) $34.19
- Trudhesa (Drug) $33.65
- AUBAGIO (Drug) $27.40
- UBRELVY (Drug) $24.34
- TYSABRI (Biological) $23.23
- NURTEC ODT (Drug) $14.77
- APTIOM (Drug) $13.34
- Ponvory (Drug) $12.15
- VRAYLAR (Drug) $11.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Bedford
Valery Lipenko, Md, MD
Neurology — Payments: $216,918
Neurology $216,918
James Barry, M.d, M.D
Neurology — Payments: $128,402
Neurology $128,402
Sandeep Kahlon, Md, MD
Neurology — Payments: $28,948
Neurology $28,948
Jerome Kane, M.d, M.D
Neurology — Payments: $28,485
Neurology $28,485
Srirekha Maddukuri, Md, MD
Neurology — Payments: $20,891
Neurology $20,891
Peter Morin, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $18,912
Neurology $18,912